Nuo Therapeutics, Inc.
AURX - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$61.51M
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $61.51 Million |
|---|---|
| Enterprise Value | $62.87 Million |
| Earnings per Share | $-0.05 |
| Beta | -104.09 |
| Outstanding Shares | 48,407,917 |
Return
| Return on Equity | 131.08% |
|---|---|
| Return on Assets | -76.63% |
| Return on Invested Capital | -161.32% |
Valuation & Multiples
| P/E Ratio | -30.38 |
|---|---|
| PEG | 53.05 |
| Price to Sales | - |
| Price to Book Ratio | -1.27 |
| Enterprise Value to Revenue | 12.09 |
| Enterprise Value to EBIT | -36.34 |
| Enterprise Value to Net Income | -32 |
| Total Debt to Enterprise | 0.03 |
| Debt to Equity | -1.18 |
Revenue Sources
No data
Last Earnings Call
Report Date
August 17, 2026
EPS Estimate
$-0.01
Consensus analyst estimateRevenue Estimate
$1.30 M
Consensus analyst estimateNext Earnings Call
Expected Date
December 2, 2026
EPS Estimate
$-0.01
Consensus analyst estimateRevenue Estimate
$1.90 M
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.01%0% |
|---|---|
| Total Invested | $4,277▼ 37.24% |
| Investors Holding | 10% |
About Nuo Therapeutics, Inc.
10 employees
CEO: David E. Jorden
Nuo Therapeutics, Inc. operates as a regenerative medicine company, specializing in the development, commercialization, and marketing of advanced cell-based technologies. These solutions are engineered to leverage the human body's inhere...